Specific antibodies elicited by a novel DNA vaccine targeting gastrin-releasing peptide inhibit murine melanoma growth in vivo

Clinical and Vaccine Immunology

Volumn 16, Issue 7, 2009, Pages 1033-1039

  Fang, Jing ^a   Lu, Yong ^b   Ouyang, Kedong ^b   Wu, Guojun ^b   Zhang, Huiyong ^b,c   Liu, Yanhua ^b   Chen, Yingying ^b   Lin, Ming ^b   Wang, Huaqian ^b   Jin, Liang ^b   Cao, Rongyue ^b   Roque, Rouel S ^d   Zong, Li ^b   Liu, Jingjing ^b   Li, Taiming ^b  

^a RESEARCH INSTITUTE OF FORESTRY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c XINXIANG MEDICAL UNIVERSITY   (China)

^d TOURO UNIVERSITY NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA VACCINE; EPITOPE; GASTRIN RELEASING PEPTIDE; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; HLA DR ANTIGEN; PEPTIDE ANTIBODY; PLASMID VECTOR; SIGNAL PEPTIDE; TETANUS TOXOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER INVASION; CANCER TRANSPLANTATION; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA IMMUNIZATION; DRUG EFFICACY; GENETIC CODE; HELPER CELL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TANDEM REPEAT; TREATMENT OUTCOME; TUMOR MODEL; TUMOR VASCULARIZATION;

ANIMALS; ANTIBODIES; CANCER VACCINES; CELL LINE; CPG ISLANDS; EPITOPES, T-LYMPHOCYTE; GASTRIN-RELEASING PEPTIDE; INJECTIONS, INTRAMUSCULAR; LUNG NEOPLASMS; MALE; MELANOMA; MICE; MICE, INBRED C57BL; PLASMIDS; SKIN NEOPLASMS; VACCINES, DNA;

EID: 67650351914     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00046-09     Document Type: Article

References (37)

1. Alexander, J., M. F. del Guercio, A. Maewal, L. Qiao, J. Fikes, R. W. Chesnut, J. Paulson, D. R. Bundle, S. DeFrees, and A. Sette. 2000. Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses. J. Immunol. 164:1625-1633. (Pubitemid 30067283)
2. Aprikian, A. G., L. Tremblay, K. Han, and S. Chevalier. 1997. Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. Int. J. Cancer 72:498-504. (Pubitemid 27325879)
3. Cornelio, D. B., R. Roesler, and G. Schwartsmann. 2007. Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann. Oncol. 18:1457-1466.
4. Festuccia, C., A. Angelucci, G. Gravina, E. Eleuterio, C. Vicentini, and M. Bologna. 2002. Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement. Exp. Cell Res. 280:1-11.
5. Festuccia, C., F. Guerra, S. D'Ascenzo, D. Giunciuglio, A. Albini, and M. Bologna. 1998. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int. J. Cancer 75:418-431.
6. Garcia, B., E. Neninger, A. de la Torre, I. Leonard, R. Martinez, C. Viada, G. Gonzalez, Z. Mazorra, A. Lage, and T. Crombet. 2008. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine. Clin. Cancer Res. 14:840-846.
7. Guojun, W., G. Wei, O. Kedong, H. Yi, X. Yanfei, C. Qingmei, Z. Yankai, W. Jie, F. Hao, L. Taiming, L. Jingjing, and C. Rongyue. 2008. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo. Endocr. Relat. Cancer 15:149-159.
8. Hellmich, M. R., K. L. Ives, V. Udupi, M. S. Soloff, G. H. Greeley, Jr., B. N. Christensen, and C. M. Townsend, Jr. 1999. Multiple protein kinase pathways are involved in gastrin-releasing peptide receptor-regulated secretion. J. Biol. Chem. 274:23901-23909.
9. Heuser, M., T. Schlott, A. V. Schally, E. Kahler, R. Schliephake, S. O. Laabs, and B. Hemmerlein. 2005. Expression of gastrin releasing peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion. J. Urol. 173:2154-2159. (Pubitemid 40675272)
10. Jin, L., A. Zhu, Y. Wang, Q. Chen, Q. Xiong, J. Li, Y. Sun, T. Li, R. Cao, J. Wu, and J. Liu. 2008. A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice. J. Immunol. 180:58-63.
11. Jingjing, L., Y. Xue, N. Agarwal, and R. S. Roque. 1999. Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. Investig. Ophthalmol. Vis. Sci. 40:752-759.
12. Kalechman, Y., G. Strassmann, M. Albeck, and B. Sredni. 1998. Up-regulation by ammonium trichloro(dioxoethylene-0,0′) tellurate (AS101) of Fas/ Apo-1 expression on B16 melanoma cells: implications for the antitumor effects of AS101. J. Immunol. 161:3536-3542. (Pubitemid 128470651)
13. Kanashiro, C. A., A. V. Schally, K. Groot, P. Armatis, A. L. Bernardino, and J. L. Varga. 2003. Inhibition of mutant p53 expression and growth of DMS- 153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin. Proc. Natl. Acad. Sci. USA 100:15836-15841.
14. Kang, J., T. A. Ishola, N. Baregamian, J. M. Mourot, P. G. Rychahou, B. M. Evers, and D. H. Chung. 2007. Bombesin induces angiogenesis and neuroblastoma growth. Cancer Lett. 253:273-281. (Pubitemid 47017542)
15. Kayaga, J., B. E. Souberbielle, N. Sheikh, W. J. Morrow, T. Scott-Taylor, R. Vile, H. Chong, and A. G. Dalgleish. 1999. Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine. Gene Ther. 6:1475-1481. (Pubitemid 29396736)
16. Klinman, D. M., G. Yamshchikov, and Y. Ishigatsubo. 1997. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:3635-3639. (Pubitemid 127488716)
17. Kreisle, R. A., and W. B. Ershler. 1988. Investigation of tumor angiogenesis in an id mouse model: role of host-tumor interactions. J. Natl. Cancer Inst. 80:849-854.
18. Kumar, A., R. Arora, P. Kaur, V. S. Chauhan, and P. Sharma. 1992. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. J. Immunol. 148:1499-1505.
19. Lacoste, J., A. G. Aprikian, and S. Chevalier. 2005. Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility. Mol. Cell. Endocrinol. 235:51-61.
20. Levine, L., J. A. Lucci III, B. Pazdrak, J. Z. Cheng, Y. S. Guo, C. M. Townsend, Jr., and M. R. Hellmich. 2003. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Cancer Res. 63:3495-3502. (Pubitemid 36793027)
21. Papac, D. I., J. Hoyes, and K. B. Tomer. 1994. Epitope mapping of the gastrin-releasing peptide/anti-bombesin monoclonal antibody complex by proteolysis followed by matrix-assisted laser desorption ionization mass spectrometry. Protein Sci. 3:1485-1492. (Pubitemid 24314467)
22. Patel, O., C. Dumesny, A. S. Giraud, G. S. Baldwin, and A. Shulkes. 2004. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor. Biochem. Pharmacol. 68:2129-2142.
23. Patel, O., A. Shulkes, and G. S. Baldwin. 2006. Gastrin-releasing peptide and cancer. Biochim. Biophys. Acta 1766:23-41.
24. Perraut, R., A. R. Lussow, S. Gavoille, O. Garraud, H. Matile, C. Tougne, J. van Embden, R. van der Zee, P.-H. Lambert, J. Gysin, and G. del Giudice. 1993. Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvants. Clin. Exp. Immunol. 93:382-386.
25. Pullen, G. R., M. G. Fitzgerald, and C. S. Hosking. 1986. Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Methods 86:83-87. (Pubitemid 16187291)
26. Qiao, J., J. Kang, T. A. Ishola, P. G. Rychahou, B. M. Evers, and D. H. Chung. 2008. Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma. Proc. Natl. Acad. Sci. USA 105:12891-12896.
27. Rozengurt, E. 1990. Bombesin stimulation of mitogenesis: specific receptors, signal transduction, and early events. Am. Rev. Respir. Dis. 142:S11-S15.
28. Salazar, E. P., and E. Rozengurt. 1999. Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells. J. Biol. Chem. 274:28371-28378.
29. Saurin, J. C., M. Fallavier, B. Sordat, J. C. Gevrey, J. A. Chayvialle, and J. Abello. 2002. Bombesin stimulates invasion and migration of Isreco1 colon carcinoma cells in a Rho-dependent manner. Cancer Res. 62:4829-4835. (Pubitemid 34898613)
30. Tatsuta, A., H. Iishi, M. Baba, H. Yano, K. Murata, M. Mukai, and H. Akedo. 2000. Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin. Exp. Metastasis 18:657-662.
31. Tatsuta, M., H. Iishi, M. Baba, H. Narahara, N. Uedo, H. Yano, R. Yamamoto, M. Mukai, and H. Akedo. 2001. Induction by bombesin of peritoneal metastasis of gastric cancers induced by N-methyl-N′-nitro-N- nitrosoguanidine in Wistar rats. Gastric Cancer 4:14-19. (Pubitemid 32625930)
32. Wang, Y., T. Whittall, E. McGowan, J. Younson, C. Kelly, L. A. Bergmeier, M. Singh, and T. Lehner. 2005. Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells. J. Immunol. 174:3306-3316. (Pubitemid 40354034)
33. Wood, M., K. Fudge, J. L. Mohler, A. R. Frost, F. Garcia, M. Wang, and M. E. Stearns. 1997. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin. Exp. Metastasis 15:246-258.
34. Xiao, D., X. Qu, and H. C. Weber. 2002. GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells. Regul. Pept. 109:141-148.
35. Yankai, Z., Y. Rong, H. Yi, L. Wentao, C. Rongyue, Y. Ming, L. Taiming, L. Jingjing, and W. Jie. 2006. Ten tandem repeats of beta-hCG 109-118 enhance immunogenicity and anti-tumor effects of beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65. Biochem. Biophys. Res. Commun. 345:1365-1371.
36. Yi, H., Y. Rong, Z. Yankai, L. Wentao, Z. Hongxia, W. Jie, C. Rongyue, L. Taiming, and L. Jingjing. 2006. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65. Vaccine 24: 2575-2584. (Pubitemid 43290389)
37. Yoshikawa, N., K. Nakamura, Y. Yamaguchi, S. Kagota, K. Shinozuka, and M. Kunitomo. 2003. Effect of PKC412, a selective inhibitor of protein kinase C, on lung metastasis in mice injected with B16 melanoma cells. Life Sci. 72:1377-1387. (Pubitemid 36084382)